Aspire Biopharma is developing next generation delivery of medicine that could have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.

Aspire’s technology comes from a new mechanism of action which allows for rapid absorption under the tongue. Benefits of “rapid absorption” are to provide nearly fast treatment impact and also allows high dose absorption.

Our technology can be applied to any number of proven drugs and supplements, such as analgesics, erectile dysfunction, and traumatic brain injury drugs.